2015 American Transplant Congress Archives - Page 20 of 170

C1q Reactivity and IgG Subtypes After HLA Antibody Removal Therapy With Carfilzomib in Thoracic Transplant Recipients

A. Zeevi, M. Marrari, C. Bentlejewski, J. Pilewski, M. Morrell, J. McDyer, M. Shullo, J. Teuteberg, C. Bermudez, C. Ensor.
Calcineurin (CNI) Exposure Reduces the Risk of Post-Transplant DSA After Deceased Donor Kidney Transplantation

R. Pelletier, A. Rajab, G. Bumgardner, M. Henry.
Calcineurin Inhibitor-Free Immunossupresion After Kidney Transplantation, Using Everolimus De Novo – Single Center Experience

M. Stronka, Z. Adamska, L. Cichanska, J. Kubiak, M. Gamrat, M. Karczewski.
Calcineurin Inhibitors (CNI) Minimization Associated With Mammalian Target of Rapamycin Inhibitors (i-mTOR) to Improve Renal Function in Renal Grafts from Uncontrolled Donation After Cardiac Death Donors (UDCDD)

M. Molina,¹ E. Gutierrez,¹ S. González-Sanchidrian,² E. González,¹ J. Cabrera,¹ N. Polanco,¹ A. Hernández,¹ A. Sevillano,¹ M. Praga,¹ A. Andres.¹
Calcineurin-Inhibitor Conversion to mTOR Inhibitor in Renal Transplant Recipients Leads to Worse Long Term Clinical Outcomes

A. Alvarado,¹ A. Shetty,¹ O. Traitanon,¹ J. Leventhal,¹ V. Mas,² D. Chhabra,³ J. Matthews,¹ L. Gallon.¹
Campath Induction With Triple Maintenance Therapy in African American Kidney Transplant Recipients: Less Infections But Worse Graft Survival

M. Gillespie, F. Rasetto, B. Masters, T. Sparkes, B. Ravichandran, M. Moss, A. Haririan.
Can Gene-Expression Profiling Score Help Explain the Adverse Clinical Outcomes Seen in Gender-Mismatched Heart Transplants?

N. Sulemanjee,¹ P. Prasad,² T. Wolf,² V. Thohan,¹ J. Teuteberg.³
Can MitoQ Improve Renal and Mitochondrial Function Following Cold Storage and Transplantation?

L. MacMillan-Crow,¹ N. Parajuli,¹ D. Borja-Cacho.
Can Post-Transplant C-Peptide Be Used as an Indicator of Pancreas Graft Failure?

R. Carrico,¹ J. Fridell,² J. Odorico,³ R. Stratta,⁴ K. Tyler,¹ S. Niederhaus,⁵ R. Kandaswamy,⁶ J. Fisher,⁷ O. Olaitan,⁸ M. Mujtaba.²
Can the Need for Graft Nephrectomy After Late Renal Transplant Failure Be Predicted?

K. Bunthof, C. Verhoeks, L. Hilbrands.
Can We Use MDRD or CKD-EPI Equation for Donor Selection?

B. Moura, D. Machado, F. Agena, F. Paula, W. Nahas, E. David-Neto, F. Lemos.
Cancer Mortality Among Recipients of Solid Organ Transplant in Ontario

S. Acuna,^1,2,3 K. Fernandes,⁴ C. Daly,^2,3 L. Hicks,³ R. Sutradhar,^1,4 S. Kim,^1,4 N. Baxter.^1,2,3,4
Cardiac Troponin T (cTNT) in the Assessment of Kidney Transplant (KTx) Benefit and Risk

F. Cosio,¹ A. Grupper,¹ P. Dean,² H. Amer.¹
Cardiac Xenotransplantation: Reconstituted B Cells After Rituxan Treatment Maintain Their Repertoire But Have a Muted Response to Xenoantigens

A. Singh,¹ P. Corcoran,¹ B. Lewis,² M. Thomas,² D. Ayers,³ K. Horvath,¹ M. Mohiuddin.¹
Cardiosphere-Derived Cells from Cadaver Can Improve Heart Function in a Model of Non-Ischaemic Dilated Cardiomyopathy

J. Wu,^1,2 Y. Sun,^1,2 M. Tan,³ D. Chi,^1,2 M. Zhang,^1,2 K. Kang,⁴ X. Jin,⁵ B. Yu.^1,2
Causes of Poor Renal Function of Kidney Transplants from Uncontrolled Donation After Cardiac Death Donors (UDCDD)

M. Molina, E. González, E. Gutiérrez, E. Morales, E. Hernández, A. Sevillano, N. Polanco, J. Cabrera, M. Praga, A. Andres.
CD27^low NK Cells Prolong Allograft Survival in Mice By Inhibiting CD8⁺ T Cell Responses Through Controlling Graft-Derived Donor DCs

A. Kroemer,^1,2 M. Lantow,¹ E. Eggenhofer,¹ M. Sabet-Baktach,¹ P. Renner,¹ H. Schlitt,¹ E. Geissler.¹
CD28 Saturation by FR104, a Non-Activating CD28 Antagonist Fab in a Non-Human Primate Cardiac Allograft Model

W. Sun,¹ A. Azimzadeh,¹ G. Braileanu,¹ T. Zhang,¹ D. Amoako,¹ L. Burdorf,¹ B. Vanhove,² R. Pierson III.
CD28-Directed Therapy Prolongs Survival in a Non-Human Primate Kidney Transplant Model

L. Higginbotham,¹ D. Mathews,¹ C. Breeden,¹ W. Wakwe,¹ C. Larsen,¹ S. Nadler,² A. Adams.¹
CD3+CD4+ROR gamma t+ TH17 Cells Do Not Play a Critical Role in Islet Allograft Rejection

M. Koulmanda, Z. Fan.
CD4 T Cell Mediated Help Is Required for Endogenous Memory CD8 T Cell Proliferation in Cardiac Allografts Subjected to Prolonged Cold Ischemic Storage

H. Tsuda,^1,4 T. Tanaka,^2,4 N. Kohei,^3,4 D. Kish,⁴ W. Baldwin,⁴ A. Valujskikh,⁴ R. Fairchild.⁴
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment

R. Hotta,¹ M. Ohira,² T. Matsuura,¹ I. Muraoka,¹ P. Tryphonopoulos,¹ J. Fan,¹ A. Tekin,¹ H. Ohdan,² A. Tzakis,³ R. Vianna,¹ S. Nishida.¹
CD8 T Cell Biomarkers Improves the Capacities of the Kidney Transplant Failure Score for the Long-Term Prognostic of Kidney Graft Failures

N. Degauque,^1,2 M. Yap,¹ G. Tilly,^1,3 P. Guerrif,² M. Giral,² S. Brouard,^1,2 Y. Foucher.^2,3
CD8⁺TCR^– Bone Marrow Facilitating Cells Prime Migration and Enhance Homing of Hematopoietic Stem and Progenitor Cells

Y. Wen,¹ Y. Huang,¹ T. Miller,¹ S. Ildstad.^1,2
Cell Type of the Tolerizing Inoculum Plays a Role in the Formation of of Molecular Chimerism in Murine Neonatal Tolerance

X. Wang,¹ H. Mewhort,¹ S. Wang,¹ S. Tollenaar,¹ K. Tao,¹ L. West.^1,2,3
Cellular Mechanism of Enhanced Alloimmunity by Ischemia Reperfusion Injury

Z. Solhjou, M. Uehara, S. Ohori, M. McGrath, J. Azzi, S. Tullius, R. Abdi.
Center Volume Is Associated With Early Graft Failure After Living Donor Kidney Transplantation

B. Shelton, P. MacLennan, R. Reed, D. Sonnier, M. Hanaway, J. Goodman, C. Young, M. Deierhoi, J. Locke.
Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients

J. Locke,¹ R. Reed,¹ S. Mehta,¹ C. Durand,² R. Mannon,¹ P. MacLennan,¹ B. Shelton,¹ M. Martin,¹ H. Qu,¹ R. Shewchuk,¹ D. Segev.²
Center-Level Variation of Simultaneous Liver-Kidney Utilization

X. Luo, A. Massie, D. Segev.
CFZ533: Assessment of Immunomodulatory Activity Following Single Doses of a Novel Anti-CD40 mAb in Healthy Volunteers

A. Slade,¹ J. Doucet,² P. Koo,¹ P. Espie,² J. Rush,² C. Tomek,³ J. Klupp.²
Change in Frailty Between Evaluation for Kidney Transplantation and Transplantation

M. McAdams DeMarco, E. King, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.
Change in Frailty Status Over Time Among In-Center Hemodialysis ESRD Patients in the ACTIVE/ ADIPOSE Study

B. Tao, J. Gander, N. Kutner, S. Pastan, R. Zhang, R. Patzer.
Change in Health-Related Quality of Life Between Evaluation for Kidney Transplantation and Transplantation

M. McAdams-DeMarco, E. King, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.
Change in Physical Function Following Kidney Transplantation

E. Lorenz, A. Cheville, B. Kotajarvi, F. Cosio, N. LeBrasseur.
Changes in Acceptances Patterns Under Share 35

K. Washburn, E. Edwards, A. Harper.
Changes in Donor Specific Antibodies (DSA) First Year After Kidney Transplant (KTX): Implications for Graft Histology and Survival

F. Cosio,¹ C. Schinstock,¹ L. Cornell,³ F. de Teresa,¹ M. Stegall.²
Changes in Health Related Quality of Life (HRQOL) in Pediatric Liver Transplant (LT) Recipients During Protocolized Immunosuppression Withdrawal (ISW): The iWITH Trial

S. Mohammad,¹ S. Sundaram,² V. Venkat,³ M. Martinez,⁴ J. Lopez,⁵ J. Magee,⁵ E. Alonso,¹ S. Feng.⁶
Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients

A. Yildiz,^1,4 M. Cavusoğlu,¹ S. Adin,² Y. çaliskan,¹ A. Ozkok,¹ H. Tasçi,³ G. Deniz,² M. Sariyar.³
Changes in Utilization, Discard, and Outcomes Associated With Hepatitis C (+) Donor Livers in the Era of Direct Acting Anti-Retroviral Therapy

M. Bowring, L. Kucirka, X. Luo, A. Massie, D. Segev, C. Durand.
Changing Demographics of HIV+ Liver Transplant Candidates

C. Durand, S. Gustafson, J. Locke, J. Snyder, B. Shelton, R. Reed, P. MacLennan, S. Mehta, A. Nellore, D. Segev.
Characteristics and Consequences of Renal Allograft Rejections Due to Nonadherence

S. Patel, S. Kuten, J. Everett, J. Loucks-DeVos, L. Gaber, A. Gaber, R. Knight.
Characteristics and Outcomes of Kidneys Procured from Donors With KDPI > 80%

M. Doshi, I. Hall, F. Weng, B. Schroppel, J. Ficek, R. Hasz, H. Thiessen-Philbrook, R. Formica, P. Reese, C. Parikh.
Characteristics and Outcomes of Patients With Incidental Hepatocellular Carcinoma Detected in the Explanted Liver Following Transplant

M. Goh, J. Ali, G. Pettigrew.
Characteristics and Outcomes of Renal Transplant Recipients With Hemolytic Uremic Syndrome: An OPTN Registry Analysis

B. Tanriover,¹ M. MacConmara,² R. Saxena,¹ Y.-M. Shen.³
Characteristics of HIV Infected Patients Waitlisted for Kidney Transplantation

N. Law,¹ A. Doyle,¹ A. Sharma,¹ G. Malat,² T. Bias,¹ K. Ranganna,¹ D. Lee.¹
Characteristics of IgGs Produced in Neu5Gc and α1-3 Gal Double Knock-Out Pigs

A. Salama,^1,2 S. Conchon,¹ A. Perota,³ B. Martinet,¹ J.-P. Judor,¹ G. Evanno,¹ S. Le-Bas Bernardet,¹ L. Le Berre,¹ J. Hervouet,¹ D. Minault,¹ J.-P. Concordet,⁴ E. Dugast,¹ B. Vanhove,¹ J. Abadie,⁵ N. Gaide,⁵ I. Lagutina,³ R. Duchi,³ G. Lazzari,³ D. Sachs,⁶ O. Gauthier,⁷ S. Brouard,¹ E. Cozzi,⁸ G. Blancho,¹ H. Perreault,⁹ J.-M. Bach,¹⁰ C. Galli,^3,11 J.-P. Soulillou.¹
Characterization of a Nude Mouse Model of Allosensitization Conditioned by Adoptive Transfer of Follicular T Helper Cells

I. Kim, N.-N. Chai, S. Jordan, A. Klein, G. Wu.
Characterization of Natural T Effector Memory Cells Specific for Collagen type V, k-α-1-Tubulin and Vimentin

J. Sullivan,¹ D. Wilkes,² T. Mohanakumar,³ W. Burlingham.¹
Characterization of Peripheral Blood T and B Cells of Sensitized Kidney Transplant Recipients With Long Term Stable Graft Function

N. Galante,¹ M. Fernandes,¹ F. Agena,¹ A. Triboni,¹ G. Freitas,¹ A. Aguirre,¹ W. Nahas,¹ V. Coelho,² E. David-Neto.¹
CHBP in Preservation Solution and Autologous Blood Perfusate Ameliorates Ischemia Reperfusion Injury in Isolated Porcine Kidneys

C. Yang,¹ S. Hosgood,² H. Carly,² P. Meeta,² Y. Long,³ T. Zhu,¹ M. Nicholson,² B. Yang.²
CHBP Suppresses Acute Rejection by Inhibition Maturation of Dendritic Cells though Jak-2/STAT3/SOCS1 Signal in Rat Kidney Transplantation

C. Yang,¹ Y. Zhang,¹ J. Wang,¹ L. Li,¹ L. Wang,² M. Xu,¹ Y. Long,³ R. Rong,¹ T. Zhu.¹
Chemokine Receptor 5 Blockade Modulates Inflammation and Immunity in Renal Ischemic Reperfusion Injury

K. Yoo,¹ S. Han,¹ J. Park,¹ E. Bae,¹ J. Park,¹ J. An,¹ J. Lee,¹ D. Kim,¹ Y. Kim,^1,2 S. Yang.²
Chest Wall,Thymus, and Heart Transplant: Pushing the Boundary of Solid Organ Allotransplantation

G. Torregrossa,¹ M. Sosin,² G. Gerosa,³ A. Dorafshar.²
Chimeric Patients Who Undergo Combined Facilitating Cell-Enriched/HSC/Renal Transplant Exhibit Robust TCR Repertoire

I. Konieczna,¹ J. Mathew,¹ J. Miller,¹ S. Ildstad,^2,3 J. Leventhal.¹
Chimeric Thymus Versus Antigen Presenting Thymus for the Induction of Tolerance: Donor DCs in Vascularized Thymus Grafts Play an Essential Role in the Induction of Tolerance

K. Yamada, M. Sekijima, A. Kawai, T. Tanabe, M. Tasaki, V. Villani, I. Hanekamp, A. Shimizu, D. Sachs.
Chimerism for Early Detection of Graft Versus Host Disease in Intestinal Transplantation

J. Garcia, T. Beduschi, P. Ruiz, A. Tekin, J. Fan, S. Nishida, G. Selvaggi, L. Cubley, R. Vianna.
Chronic Active Antibody Mediated Rejection (cABMR): Treatment, Outcomes and Predictors of Graft Loss in a Large Case Series

R. Redfield,¹ T. Ellis,¹ W. Zhong,¹ T. Zens,¹ M. Rizzari,¹ J. Scalea,¹ L. Jacobson,¹ D. Mandelbrot,¹ S. Parajuli,¹ B. Muth,¹ M. Mohamed,¹ S. Panzer,¹ B. Astor,¹ M. Samaniego,² D. Kaufman,¹ A. Djamali.¹
Clinical and Biochemical Results of BK Virus Nephropathy in Kidney Allograft Recipients

B. Canbakan,¹ I. Akdağ,¹ ö. Merhametsiz,¹ ö. Yayar,² E. Oğuz,¹ M. Kiliç,³ D. Ayli.¹
Clinical and Immunologic Risk Factors Associated With Donor-Specific Antibody (DSA) Formation Following Renal Transplantation

C. Johnson,¹ S. Park,¹ J. Schiller.²
Clinical and Immunological Update 15 Years After the First VCA – Subsequent Kidney Transplantation After a Bilateral Hand Transplant

A. Weissenbacher,¹ G. Pierer,² M. Gabl,³ M. Ninkovic,¹ T. Hautz,¹ J. Grahammer,¹ B. Zelger,⁴ B. Zelger,⁵ G. Brandacher,⁶ S. Schneeberger.¹
Clinical and Pathologic Predictors of Response to Belatacept Conversion

S. Patel, H. Morris, D. Cohen, S. Mohan, L. Ratner, R. Crew.
Clinical and Radiological Predictors of Transplant Renal Artery Stenosis (TRAS)

H. Wadei,¹ D. Hodge,² L. White,² A. Ayub,³ N. Aslam,³ T. Gonwa,¹ G. Frey,⁴ D. Sella,⁴ M. Mai.¹
Clinical and Virologic Outcomes in High-Risk Adult EBV D+/R- Organ Transplant Recipients

D. Kumar, N. Patil, S. Husain, C. Chaparro, A. Humar.
Clinical Consequences of Immune-Mediated Allograft Arteriosclerosis: A Population Based Study

A. Loupy, Vernerey, Viglietti, Aubert, Duong van Huyen, Bruneval, Empana, Suberbielle, Glotz, Jouven, Legendre, Lefaucheur.
Clinical Course of Pre-Existing Monoclonal Gammopathies Following Kidney Transplant

C. Johnson.
Clinical Impact of 18F-FDG-PET/CT in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma

S. Lee, S. Kim.
Clinical Outcome of Patients With De Novo C1q Binding Donor-Specific HLA Antibodies After Renal Transplantation

J. Bamoulid,¹ A. Roodenburg,² O. Staeck,¹ C. Schoenemann,² N. Lachmann,² K. Budde.¹
Clinical Outcomes of Kidney Transplan Recipients After Sirolimus Or Everolimus Conversion. Experience in a Single Center

L. Mesa, E. Manzi, M. Valderrama, J. Posada, J. Schweineberg, C. Duran, G. Echeverri, J. Villegas, O. Serrano, L. Caicedo.
Clinical Outcomes of Living Kidney Donors With Medullary Sponge Kidney

W. Cheungpasitporn, C. Thongprayoon, B. Brabec, W. Kittanamongkolchai, S. Erickson.
Clinical Relevance of C3d-Binding Donor-Specific Antibodies in Late Kidney Allograft Failure

J. Lan, D. Gjertson, Y. Zheng, DeKAF Investigators, E. Reed, M. Cecka.
Clinical Significance of Estimated DSA MFI Values at 1,000 C1q MFI for Differentiation Between Harmful and Harmless DSA

K. Horimi,¹ T. Akaza,² K. Kuroki,² S. Sakamoto,² Y. Matsuoka,¹ Y. Watarai,² S. Narumi,² A. Katayama,³ K. Uchida,¹ T. Kobayashi.⁴
Clinical Significance of Multidetector Coronary Computed Tomography Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Asymptomatic Kidney Transplantation Recipients

S. Lee,¹ K. Huh,³ B. Kim,² B. Choi,⁴ Y. Kim,⁴ Y. Kim,³ B. Kim.²
Clinical Subclassifiation of ABMR Phenotypes: Recognizing Variation in Presentation

P. Halloran, M. Lopez, I. Salazar, J. Chang.
Clinical Use of Gene-Expression Profiling to Monitor for Rejection After Cardiac Transplantation – Which Patients and When?

J. Teuteberg,¹ M. Shullo,¹ T. Wolf,² P. Prasad,² G. Ewald.³
Clinical Utility of Allospecific CD154+T-Cells in Children With Liver Or Intestine Transplantation (LTx, ITx)

K. Soltys, G. Bond, G. Mazariegos, C. Ashokkumar, K. Dirling, L. O'Toole, P. Kachmar, T. Hartle, D. Martin, C. Trautz, R. Sindhi.
Clinically Relevant Anti-TCR mAb Induction Plus Brief Rapamycin Therapy Can Achieve Long-Term Vascularized Composite Allograft (VCA) Survival

L. Wang, A. Samanta, J. Huang, T. Bhatti, Z. Wang, R. Han, L. Levin, M. Levine, W. Hancock.
Clinically Relevant Wound Events With Everolimus-Based Immunosuppressive Regimen: Post-Hoc Analysis from a Randomized Heart Transplant Study

A. Zuckermann,¹ M. Rinaldi,¹ N. Yonan,¹ S.-S. Wang,¹ G. Dong,² P. Lopez.²
Clinicopathological Scenarios (CPS) Defined by Viremia, Creatinine and Histology in Polyomavirus Nephropathy Differ in 1st and 2nd (Follow-Up) Biopsy

C. Drachenberg, M. Chaudhry, F. Yang, R. Ugarte, A. Haririan, M. Mavanur, C. Cangro, B. Thomas, N. Costa, E. Ramos, M. Weir, J. Papadimitriou.
Closing the Knowledge Gap: The Successful Launch of an Interactive Website Dedicated to Information on Living Kidney Donor Transplantation

D. Slaats,¹ W. Zuidema,¹ J. van de Wetering,¹ D. Hesselink,¹ T. Terkivatan,² M. Betjes.¹
Clusterin-Regulated Transcriptome in the Kidney During Ischemia-Reperfusion

G. Dairi, Q. Guan, A. Haegert, C. Collins, M. Gleave, C. Nguan, C. Du.
CMV IgG Provides Similar Anti-CMV Efficacy as Valganciclovir in High-Risk Organ Transplant Recipients, With Reduced Costs

N. Pilch, D. Taber, C. Schaffner, S. Nadig, J. McGillicuddy, C. Bratton, P. Baliga, K. Chavin.
CMV prevalence in Mauritian and Indonesian Cynomolgus Macaques: Significance in Transplantation and CMV Disease Models

K. Premanand,¹ E. Szilagyi,¹ J. Yu,¹ R. Patel,¹ A. Antony,¹ M. Willman,² D. Berman-Weinberg,² D. Han,² A. Vaidya,³ E. Silva,³ K. McHenry,³ D. Salomon,⁴ N. Kenyon,² A. Bartholomew.¹
CMV-Specific CD154+T-Cells and CMV Disease Status After Liver Or Intestine Transplantation (LTx, ITx)

C. Ashokkumar,¹ M. Ningappa,¹ G. Mazariegos,¹ K. Soltys,¹ G. Bond,¹ C. Trautz,¹ M. Green,² M. Michaels,² R. Sindhi.¹
CN Inhibition (But Not mTOR Inhibition) of a Novel CD8⁺ T Cell Regulatory Mechanism Results in Higher Alloantibody Posttransplant

J. Zimmerer, S. Elzein, C. Wright, G. Bumgardner.
CO2 Angiography Provides a Safe Alternative to Iodinated Contrast Agents in the Diagnosis and Endovascular Treatment of Transplant Renal Artery Stenosis

B. Gelb,¹ N. Cayne,² J. Benstein,³ G. Morgan,¹ K. Bortecen,¹ M. Hamshow,¹ L. Teperman.¹
Cognate Events in Antibody- Vs. T Cell-Mediated Rejection: A Molecular Perspective

M. Parkes,¹ P. Halloran,¹ L. Hidalgo.²
Combination of Clinical and Genetic Factors for Delayed Kidney Graft Function Prediction

A. Goncalves-Primo,^1,2 E. Campos,^1,2 J. Medina-Pestana,^2,3 H. Tedesco-Silva,³ M. Gerbase-DeLima.^1,2
Combination of Non-HLA and HLA-DSA Antibodies Identifies Liver Transplants Recipients With Highest Risk for Fibrosis Progression and Mortality

J. O'Leary,¹ J. Cai,² H. Heidecke,³ L. Jennings,¹ A. Philippe,⁴ V. Harbour,¹ R. Catar,⁴ P. Terasaki,² G. Klintmalm,¹ D. Dragun.⁴
Combined Anti-IL6R and CTLA4Ig Therapy Attenuates Recall Alloantibody Responses in a Mouse Model of HLA Sensitization

N.-N. Chai, G. Wu, I. Kim, A. Klein, S. Jordan.
Combined Bone Marrow Plus Liver Transplantation in Cynomolgus Monkeys

J. Weiner, Y. Kato, R. Duran-Struuck, M. Martinez, S. Baker, P. Alonso, J. Zitsman, A. Wu, P. Houck, T. Pinyavat, J. Lefkowitch, S. Chaudhry, T. Kato, M. Sykes, A. Griesemer.
Combined Hepatitic/Cholangiopathic Lesion in HIV-HCV Co-Infected Liver Transplant Recipients Associated With Graft Loss

J. Harbell,¹ A. Doherty,² L. Ferrell,² B. Barin,³ N. Terrault,¹ P. Stock.¹
Combined Robotic Kidney Transplantation and Sleeve Gastrectomy in Obese Recipients: Initial Results from Prospective Randomized Study

I. Tzvetanov, G. D'Amico, G. Georgiev, H. Jeon, R. Garcia-Roca, E. Benedetti, J. Oberholzer.
Come Again? A Retrospective Cohort Study of Rehospitalization Following Expanded Criteria Donor Renal Transplantation

M. Hung,¹ C. Dunn,¹ A. Holtzman,¹ E. Bellin,² S. Greenstein.²
Come Again? Part 2, Exploring Causes for Increased Rehospitalization in ECD Kidney Recipients

C. Dunn, M. Hung, S. Greenstein.
Comparative Survival Benefits and Costs of an Eplet and Broad Antigen Based Matching System in Deceased Donor Kidney Transplant Allocation Among Indigenous Australians

H. Do Nguyen,¹ G. Wong,^2,3 J. Chapman,² J. Craig,^2,3 L. D'Orsogna,⁴ W. Lim.^1,5
Comparison of Clinical Outcomes Between in the Spousal Donor Kidney Tranplants: Wife-to-Husband Versus Husband-to-Wife

K. Jun,¹ H. Kim,¹ M. Kim,¹ K. Park,² S. Ahn,¹ J. Hwang,¹ S. Kim,¹ S. Park,¹ S. Kim,¹ J. Kim,¹ I. Moon.¹
Comparison of Creatinine Based Estimated Glomerular Filtration Rate (eGFR) and Iothalamate-Measured GFR (mGFR) Following Simultaneous Pancreas – Kidney Transplantation

N. Sarabu, J. Augustine, K. Woodside, D. Hricik, A. Padiyar, E. Sanchez.
Comparison of Efficacy and Renal Function in KidneyTransplant Recipients Receiving Tacrolimus (TAC)-Based Immunosuppressive Regimens in Combination With Everolimus (EVR) or Mycophenolate (MPA)

A. Ferreira,¹ C. Felipe,¹ P. Ueno,¹ P. Hannun,¹ P. Ruppel,¹ T. Sandes-Freitas,¹ H. Proença,³ J. Medina- Pestana,¹ H. Tedesco-Silva.¹
Comparison of Efficacy of Prophylactic Antivirus Therapies on Outcomes of Kidney Transplantation in Hepatitis B Virus Carriers

G. Chen, C. Wang, J. Qiu, J. Li, L. Chen.
Comparison of Liver Transplant Outcomes for Recipients With MELD <35 Vs. >35

V. Kirchner, S. Chinnakotla, R. Kandaswamy, W. Payne, T. Pruett.
Comparison of Markers of Inflammation Between Dialysis Patients With and Without Failed Kidney Allograft

R. Villca-Gonzales, R. Vazquez-Apodaca, D. Hernandez-Ramirez, L. Llorente-Peters, J. Alberu, L. Morales-Buenrostro.
Comparison of One-Year Outcomes in High Risk Kidney Transplantation: ABO Incompatible and DSA Positive/CDC-AHG Negative

N. Townamchai,¹ W. Chancharoenthana,¹ S. On-Pun,² S. Wattanatorn,¹ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
Comparison of Pharmacokinetics and Pharmacogenomics of Once-Daily Extended-Release MeltDose® Tacrolimus Tablets (Envarsus® XR) Vs. Twice-Daily Tacrolimus Capsules in Stable African American Kidney Transplant Patients: A Randomized Cross-Over Study

J. Trofe-Clark,^1,2 D. Brennan,³ P. West-Thielke,⁴ M. Milone,⁵ M. Lim,² R. Bloom.²
Comparison of Renal Outcomes for Liver Transplant Recipients With Pretransplant Renal Dysfunction Receiving Sirolimus Or Tacrolimus With Rabbit Antithymocyte Globulin Induction

B. Duhart,¹ W. Ally,² V. Rao,³ A. Krauss,⁴ J. Eason,³ J. Vanatta.³
Comparison of Risk Factors and Outcomes of Daptomycin-Susceptible and -Nonsusceptible Enterococcus Infections in Liver Transplant Recipients

J. Lewis, K. Enfield, H. Cox, A. Mathers, C. Sifri.
Comparison of T Regulatory (Treg) Cell Function Pre- and Post-Lung Transplantation Shows a Major Negative Impact of Immunosuppression on Treg Function

T. Akimova,¹ J. Diamond,² D. Wilkes,³ D. Lederer,⁴ J. Christie,² W. Hancock.¹
Comparison of the Clinical Outcome and Surgical Invasiveness for Living Donor Nephrectomy Between Conventional Laparoscopic Surgery and Single-Port Surgery

M. Saito, S. Satoh, R. Yamamoto, H. Tsuruta, S. Akihama, T. Inoue, S. Narita, N. Tsuchiya, T. Habuchi.
Complement Inhibition Via the Lectin Pathway Improves Experimental Cardiac Graft Survival

J. Kindermann,^1,2 M. Waechter,^1,2 R. Bruno,¹ M. Langenmayer,³ T. Dudler,⁴ W. Schwaeble,⁵ E. Kleinert,¹ T. Mayr,^1,2 H. Christian,² R. Wanke,³ J.-M. Abicht,⁶ S. Guethoff.¹
Comprehensive Study of 3 Nomenclatures to Discriminate CD8 Subsets in Healthy Volunteers and in Kidney Transplant Recipients

M. Yap,^1,3 G. Tilly,^1,3 M. Giral,^1,2 S. Brouard,^1,2 N. Degauque.^1,2
Concerted T-Cell Activity Against Early and Late BKV-Antigens Is Necessary for Viral Clearance

B. Weist,^1,2 M. Schmueck,² M. Dziubianau,² P. Reinke,^1,2 N. Babel.^1,2
Conditioning of Mesenchymal Stromal Cells With mTOR Inhibitor Enhances Regenerative Properties of Secretome and Attenuates Vascular Calcification

B. Hegner,¹ C. Kurth,¹ T. Schaub,¹ C. Lange,² D. Dragun.¹
Consideration of the Futility of Transplant: 50% Mortality at 5 Years

S. Asrani, G. Saracino, J. O'Leary, G. Klintmalm, J. Trotter.
Constitutively Upregulated Expression of Complement and Matrix Transcripts in Kidney Transplant Recipients Who Develop Acute Rejection

K. Keslar,¹ J. Reid-Adam,⁴ E. Kwon,⁴ D. Hricik,⁵ E. Poggio,^2,3 P. Heeger,⁴ R. Fairchild.^1,3
Controlled DCD Pancreas Transplantation : A Single Centre Experience

M. Voskuil, S. Mittal, A. Muthusamy, J. Gilbert, S. Sinha, I. Quiroga, S. Reddy, P. Friend, E. Sharples, A. Vaidya, R. Ploeg.
Controlled Hemodilution in Infant Liver Transplants: A Single Center Experience

T. Todo,¹ A. Gallo,¹ J. Mendoza,² T. Pham,¹ C. Esquivel.¹
Controlling Alloreactive B Cell Responses in Sensitized Recipients With CTLA-4Ig

J. Chen,¹ Q. Wang,¹ D. Yin,¹ V. Vu,¹ R. Sciammas,² A. Chong.¹
Controlling for Socioeconomic Barriers Reduces Racial Disparities in Transplant Pursuit

A. Waterman,¹ J. Peipert,¹ C. Kynard-Amerson,¹ A.-M. McSorley,¹ A. Paiva,² M. Robbins,² L. Peace.³
Conversion from Immediate to Prolonged Release Tacrolimus Did Not Change Intra-Patient Variability in Renal Transplant Patients

T. El-Nahhas,^1,2 M. Moreton,² J. Popoola,³ S. Abat,³ A. Johnston,^1,2 I. MacPhee.³
Conversion to Belatacept After Kidney Transplantation Does Not Alter Immunophenotype

M. Matz,¹ K. Fabritius,¹ C. Lorkowski,¹ J. Liu,¹ S. Brakemeier,¹ N. Unterwalder,² H.-H. Neumayer,¹ K. Budde.¹
Correlates and Consequences of Gout Among Living Kidney Donors

N. Lam,¹ A. Garg,¹ D. Segev,² M. Schnitzler,³ H. Xiao,³ D. Axelrod,⁴ J. Tuttle-Newhall,³ D. Brennan,⁵ B. Kasiske,⁶ K. Lentine.³
Correlates of Clinical Course of Polyomavirus BK Infection With Long-Term Outcome of BK Virus-Associated Nephropathy in Renal Transplant Patients

G. Huang, C.-X. Wang, J.-G. Fei, J. Qiu, S.-X. Deng, J. Li, G.-D. Chen, Q. Fu, R.-H. Deng, L.-Z. Chen.
Correlation Between C3d-Binding De Novo Donor Specific HLA Antibodies and Rejection in Kidney Transplant Recipients

M. Cusick, K. Haarberg, J. Friedewald, A. Tambur.
Correlation Between Level of Biomarkers Measured in Perfusate of Machine-Preserved ECD/DCD Kidneys and Post-Transplant Graft Function

E. Ablorsu,¹ S. Zouwail,² P. Laftsidis,¹ B. Cook,¹ L. Szabo.¹
Correlation of Longitudinal Gene-Expression Profiling Score to Cytomegalovirus Infection: Results from the Outcomes AlloMap® Registry

M. Kanwar,¹ J. Yee,² G. Ewald,³ S. Murali,¹ J. Teuteberg.⁴
Correlation of Serum Creatinine-Based Equations With Radionuclide GFR in Candidates for Liver Transplantation

A. Alqallaf, A. Alam, P. Ghali, M. Cantarovich.
Cost-Effective, Simple PTC Tasting Could Be a Useful Adjunct to Selection Criteria of ARLD Patients

K. Bortecen,¹ D. Freitas,¹ C. Teperman,² M. Hamshow,¹ B. Gelb,¹ G. Morgan,¹ L. Teperman.¹
Costimulation Blockade and Bortezomib to Desensitize Rhesus Macaque and Prolong Renal Allograft Survival

J. Kwun, C. Burghuber, E. Page, A. Gibby, N. Iwakoshi, S. Knechtle.
Costimulation Blockade Prevents Rejection of Vascularized Composite Allografts

B. Oh,¹ G. Furtmüller,¹ M. Fryer,¹ J. Grahammer,² S. Schneeberger,² D. Cooney,¹ W. Lee,¹ G. Brandacher.¹
CPRA Values Are Substantially Increased for Some Candidates Subsequent to Inclusion of Unacceptable C-locus (UA-C) Antigens While Listing Practices Remain Unchanged

A. Kucheryavaya,¹ R. Bray,² A. Miller,¹ D. Tyan.³
Creation of a Functional Bio-Artificial Intestinal Segment in Rats

T. Corsello, G. Damiano, M. Tuveri, M. Montalbano, C. Rastellini, L. Cicalese.
Cross-Linking of MHC Class I Induces Unique Transcriptional Profiles Associated With Regulation of Both T and B Cells That Precedes Induction of Allo- and Auto-Immunity Leading to Obliterative Airway Disease

D. Nayak, M. Sharma, Z. Xu, A. Gelman, T. Mohanakumar.
CTLA4Ig Administered During T-Cell Priming Negates de novo Alloantibody Responses and Modulates Recall Antibody Production

G. Wu, I. Kim, N.-N. Chai, S. Jordan, A. Klein.
Cultural Domains Affecting Organ Donation in Indian Country

T. Bongiovanni,^1,3,4 J. Rawlings,² J. Trompeta,³ M. Nunez-Smith.¹
Cumulative Incidence, Risk Factors for and Impact on Survival of Severe Chronic Kidney Disease After Intestinal Transplantation: Analysis of the SRTR Database

G. Huard,¹ K. Iyer,¹ J. Moon,¹ L. Schwartz,¹ J. Doucette,² V. Nair,¹ T. Schiano.¹
Current Dialysis, Previous Kidney Transplant, and Autoimmune Disease Increase Risk for Abnormal Pap Smear in Women Undergoing Kidney Transplant Evaluation

K. Chaung,¹ Y. Zheng,¹ A. Martella,² J. Stoecker,¹ D. Cote,¹ J. Augustine,² E. Sanchez,² V. Humphreville,² J. Ammori,² K. Woodside.²
Current Status of US Intestinal and Multivisceral Transplantation: An Analysis of the UNOS Intestine Transplant Registry

J. Cai,¹ A. Qing,² G. Wu,³ M. Everly,¹ P. Terasaki.¹
Customized Reminders and Provider Notification to Improve Adherence to Immunosuppression

P. Reese, R. Bloom, J. Trofe-Clark, A. Mussell, D. Leidy, S. Levsky, J. Zhu, Y. Lin, A. Troxel, H. Feldman, K. Volpp.
CXCR4-SDF1α Blockade Reduces the Severity of Murine Heart Allograft Rejection

X. Wang,¹ J. Fu,¹ B. Wilde,¹ L. Jing,¹ J. Zhu,¹ A. Kribben,¹ O. Witzke,¹ A. Hoerning.^2,3
Cyclophosphamide as a Salvage Therapy for Combined Intravenous Immunoglobulins and Plasmapheresis Refractory Antibody-Mediated Rejection

W. Habhab,¹ A. Dada,² M. Alwassia,¹ N. Baz,² N. Zabani,¹ A. Fahmy,¹ A. Abdul Malik.¹
Cyclosporine Nephrotoxicity Is Associated With Diminished Expression of Heat Shock Protein 27 (HSP27) and Loss of Claudin-2-Dependent Intercellular Adhesion

A. Zmijewska,¹ R. Thuillier,² J. Chen,¹ J. Zmijewski,¹ R. Mannon.¹
Cytomegalovirus and BK Infections in Sensitized Kidney Transplant Recipients

S. Parajuli, B. Muth, J. Turk, M. Mohamed, D. Mandelbrot, A. Djamali.
Cytotoxic CD8 T Cell Recognition of Acquired, Intact MHC Alloantigen On Host Dendritic Cells Promotes Acute Allograft Rejection

J. Ali, S. Harper, M. Negus, E. Bolton, J. Bradley, G. Pettigrew.